# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-25-006987
Filing Date
2025-01-27
Accepted
2025-01-27 16:07:06
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE ADDITIONAL MATERIALS | ea022803802-defa14a_citius.htm | DEFA14A | 9338
2 | GRAPHIC | image_001.jpg | GRAPHIC | 511301
3 | GRAPHIC | image_002.jpg | GRAPHIC | 477655
| Complete submission text file | 0001213900-25-006987.txt |  | 1372186

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38174 | Film No.: 25559080
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)